How to Design a Cancer Vaccine: Neoantigens and MHC Science
UNC's PIRL lab founders discuss neoantigen detection, MHC prediction, and the engineering challenges of personalized cancer immunotherapy in a three-hour deep dive.
cancer vaccinesimmunotherapymachine learningbioinformatics